Tag: HIV

April 12, 2017

5 Top Pharma Stocks of Q1 2017 on the TSX

The Investing News Network takes a look at some of the best-performing pharmaceutical stocks on the TSX during the first...
April 11, 2017

Inovio Released Preliminary Results on Ebola Vaccine

Inovio Pharmaceuticals announced its Ebola vaccine showed promising preliminary results from an expanded Phase I study.
April 6, 2017

Theratechnologies Posts Financial Results For Q1 2017

Theratechnologies released their financial results for the first quarter of 2017.
April 3, 2017

GeoVax Gets Financial Award For HIV Vaccine

GeoVax Labs received a grant for $658,159 from the National Institute of Allergy and Infectious Disease in support of its...
March 30, 2017

Immune Therapeutics Applies For New US Patents

Immune Therapeutics (OTCQB:IMUN) has filed three new patent applications in the US.
March 27, 2017

GeoVax Posts Positive Results In Zika Vaccine Trial

GeoVax Labs has successfully concluded a clinical trial for its vaccine candidate GEO-ZM02 seeking protection for the Zika virus.
December 8, 2016

How Personalized Medicine Can Change Your Investment Strategy

Pharmaceutical companies have developed numerous strategies to counter the patent cliff. One such tactic? Capitalizing on the personalized medicine market....